{"id":125677,"date":"2021-08-27T05:19:17","date_gmt":"2021-08-27T05:19:17","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=125677"},"modified":"2023-06-01T09:35:30","modified_gmt":"2023-06-01T09:35:30","slug":"chronic-myelogenous-leukemia","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/","title":{"rendered":"Chronic myelogenous leukemia"},"content":{"rendered":"<p>A cancerous disease of the white blood cells called myeloblasts.<\/p>\n<hr \/>\n<p>Chronic myelocytic leukemia, also known as CML, is a malignancy characterized by the abnormal buildup of white blood cells in both the bone marrow and bloodstream. This condition is marked by the proliferation of white cells, disrupting the normal functioning of the body&#8217;s immune system. The accumulation of these cells in the marrow and bloodstream can lead to various health complications and impair the body&#8217;s ability to fight infections effectively. CML requires careful medical management to control the proliferation of white cells and mitigate its impact on overall health and well-being.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A cancerous disease of the white blood cells called myeloblasts. Chronic myelocytic leukemia, also known as CML, is a malignancy characterized by the abnormal buildup of white blood cells in both the bone marrow and bloodstream. This condition is marked by the proliferation of white cells, disrupting the normal functioning of the body&#8217;s immune system. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-125677","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Chronic myelogenous leukemia - Definition of Chronic myelogenous leukemia<\/title>\n<meta name=\"description\" content=\"A cancerous disease of the white blood cells called myeloblasts.Chronic myelocytic leukemia, also known as CML, is a malignancy characterized by the abnormal buildup of white blood cells in both the bone marrow and bloodstream. This condition is marked by the proliferation of white cells, disrupting the normal functioning of the body&#039;s immune system. The accumulation of these cells in the marrow and bloodstream can lead to various health complications and impair the body&#039;s ability to fight infections effectively. CML requires careful medical management to control the proliferation of white cells and mitigate its impact on overall health and well-being.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chronic myelogenous leukemia - Definition of Chronic myelogenous leukemia\" \/>\n<meta property=\"og:description\" content=\"A cancerous disease of the white blood cells called myeloblasts.Chronic myelocytic leukemia, also known as CML, is a malignancy characterized by the abnormal buildup of white blood cells in both the bone marrow and bloodstream. This condition is marked by the proliferation of white cells, disrupting the normal functioning of the body&#039;s immune system. The accumulation of these cells in the marrow and bloodstream can lead to various health complications and impair the body&#039;s ability to fight infections effectively. CML requires careful medical management to control the proliferation of white cells and mitigate its impact on overall health and well-being.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-27T05:19:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-01T09:35:30+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/\",\"name\":\"Chronic myelogenous leukemia - Definition of Chronic myelogenous leukemia\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-08-27T05:19:17+00:00\",\"dateModified\":\"2023-06-01T09:35:30+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A cancerous disease of the white blood cells called myeloblasts.Chronic myelocytic leukemia, also known as CML, is a malignancy characterized by the abnormal buildup of white blood cells in both the bone marrow and bloodstream. This condition is marked by the proliferation of white cells, disrupting the normal functioning of the body's immune system. The accumulation of these cells in the marrow and bloodstream can lead to various health complications and impair the body's ability to fight infections effectively. CML requires careful medical management to control the proliferation of white cells and mitigate its impact on overall health and well-being.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chronic myelogenous leukemia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chronic myelogenous leukemia - Definition of Chronic myelogenous leukemia","description":"A cancerous disease of the white blood cells called myeloblasts.Chronic myelocytic leukemia, also known as CML, is a malignancy characterized by the abnormal buildup of white blood cells in both the bone marrow and bloodstream. This condition is marked by the proliferation of white cells, disrupting the normal functioning of the body's immune system. The accumulation of these cells in the marrow and bloodstream can lead to various health complications and impair the body's ability to fight infections effectively. CML requires careful medical management to control the proliferation of white cells and mitigate its impact on overall health and well-being.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/","og_locale":"en_US","og_type":"article","og_title":"Chronic myelogenous leukemia - Definition of Chronic myelogenous leukemia","og_description":"A cancerous disease of the white blood cells called myeloblasts.Chronic myelocytic leukemia, also known as CML, is a malignancy characterized by the abnormal buildup of white blood cells in both the bone marrow and bloodstream. This condition is marked by the proliferation of white cells, disrupting the normal functioning of the body's immune system. The accumulation of these cells in the marrow and bloodstream can lead to various health complications and impair the body's ability to fight infections effectively. CML requires careful medical management to control the proliferation of white cells and mitigate its impact on overall health and well-being.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/","og_site_name":"Glossary","article_published_time":"2021-08-27T05:19:17+00:00","article_modified_time":"2023-06-01T09:35:30+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/","name":"Chronic myelogenous leukemia - Definition of Chronic myelogenous leukemia","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-08-27T05:19:17+00:00","dateModified":"2023-06-01T09:35:30+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A cancerous disease of the white blood cells called myeloblasts.Chronic myelocytic leukemia, also known as CML, is a malignancy characterized by the abnormal buildup of white blood cells in both the bone marrow and bloodstream. This condition is marked by the proliferation of white cells, disrupting the normal functioning of the body's immune system. The accumulation of these cells in the marrow and bloodstream can lead to various health complications and impair the body's ability to fight infections effectively. CML requires careful medical management to control the proliferation of white cells and mitigate its impact on overall health and well-being.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/chronic-myelogenous-leukemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Chronic myelogenous leukemia"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/125677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=125677"}],"version-history":[{"count":2,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/125677\/revisions"}],"predecessor-version":[{"id":227626,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/125677\/revisions\/227626"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=125677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=125677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=125677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}